Finn Cilius Nielsen

Finn Cilius Nielsen's AcademicInfluence.com Rankings

Finn Cilius Nielsen

Biology

#13660

World Rank

#17215

Historical Rank

Biochemistry

#2410

World Rank

#2561

Historical Rank

biology Degrees

Download Badge

Biology

Finn Cilius Nielsen's Degrees

PhD Biochemistry University of Copenhagen

Why Is Finn Cilius Nielsen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Finn Cilius Nielsen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. (2008) (1343)
Ancient human genome sequence of an extinct Palaeo-Eskimo (2010) (754)
A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development (1999) (669)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) (2011) (447)
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk (2013) (405)
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population (2010) (357)
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis (2012) (332)
RNA‐binding IMPs promote cell adhesion and invadopodia formation (2006) (320)
Ascertainment biases in SNP chips affect measures of population divergence. (2010) (318)
The transcriptional program of terminal granulocytic differentiation. (2004) (286)
The genetic prehistory of the New World Arctic (2014) (285)
Hereditary breast and ovarian cancer: new genes in confined pathways (2016) (270)
NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. (2008) (257)
Molecular Composition of IMP1 Ribonucleoprotein Granules*S (2007) (212)
Collection of Blood, Saliva, and Buccal Cell Samples in a Pilot Study on the Danish Nurse Cohort: Comparison of the Response Rate and Quality of Genomic DNA (2007) (211)
The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer (2012) (207)
Dwarfism and Impaired Gut Development in Insulin-Like Growth Factor II mRNA-Binding Protein 1-Deficient Mice (2004) (207)
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations (2018) (206)
Gene expression profiles of single human mature oocytes in relation to age. (2010) (201)
Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study (2011) (198)
H19 RNA Binds Four Molecules of Insulin-like Growth Factor II mRNA-binding Protein* (2000) (172)
A Library of 7TM Receptor C-terminal Tails (2004) (171)
Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway (1995) (166)
Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing. (2009) (165)
Expression but incomplete maturation of progastrin in colorectal carcinomas. (1993) (164)
IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. (2009) (157)
Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (154)
A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. (2001) (148)
ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating β1 integrin function (2003) (144)
Helicobacter pylori Infection Induces Genetic Instability of Nuclear and Mitochondrial DNA in Gastric Cells (2009) (140)
Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses. (2014) (137)
Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood (2006) (132)
Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. (2005) (130)
Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. (1987) (126)
MicroRNAs Show Mutually Exclusive Expression Patterns in the Brain of Adult Male Rats (2009) (111)
Cytoplasmic trafficking of IGF-II mRNA-binding protein by conserved KH domains. (2002) (110)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
Weaning triggers a maturation step of pancreatic β cells. (2015) (110)
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations (2011) (107)
Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability. (2004) (107)
Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014. (2017) (107)
Translational discrimination of mRNAs coding for human insulin-like growth factor II. (1990) (104)
Relatedness mapping and tracts of relatedness for genome‐wide data in the presence of linkage disequilibrium (2009) (101)
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (2011) (101)
The molecular and cellular biology of insulin-like growth factor II. (1992) (101)
Favourable effect of TNF‐α inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novoCARD15 mutation (2006) (98)
MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling. (2009) (94)
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers (2012) (92)
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families (2009) (90)
Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression. (1997) (87)
IMP3 RNP safe houses prevent miRNA-directed HMGA2 mRNA decay in cancer and development. (2014) (87)
Downregulation of miR-125b in metastatic cutaneous malignant melanoma (2010) (86)
A guanosine quadruplex and two stable hairpins flank a major cleavage site in insulin-like growth factor II mRNA. (1994) (84)
Characterization of human exonuclease 1 in complex with mismatch repair proteins, subcellular localization and association with PCNA (2004) (81)
Control of Fetal Growth and Neonatal Survival by the RasGAP-Associated Endoribonuclease G3BP (2005) (80)
A genome-wide scan in affected sibling pairs with idiopathic recurrent miscarriage suggests genetic linkage. (2011) (79)
Pathology of Breast andOvarian Cancers among BRCA 1 and BRCA 2 Mutation Carriers : Results from the Consortium of Investigators of Modi fi ers of BRCA 1 / 2 ( CIMBA ) (2011) (78)
mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts. (2013) (75)
Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma. (2012) (75)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
HNPCC mutations in the human DNA mismatch repair gene hMLH1 influence assembly of hMutLα and hMLH1–hEXO1 complexes (2001) (71)
Endonucleolysis in the turnover of insulin-like growth factor II mRNA. (1992) (70)
ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice. (2002) (69)
C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors (2001) (69)
Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins. (2003) (69)
Developmental expression of the gastrin and cholecystokinin genes in rat colon. (1993) (67)
Tetranectin is a novel marker for myogenesis during embryonic development, muscle regeneration, and muscle cell differentiation in vitro. (1998) (67)
Shared heritability and functional enrichment across six solid cancers (2018) (67)
Functional characterization of BRCA1 gene variants by mini-gene splicing assay (2014) (64)
Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain. (2006) (64)
Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency. (2003) (63)
Plasticity of Adult Human Pancreatic Duct Cells by Neurogenin3-Mediated Reprogramming (2012) (61)
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2012) (60)
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants (2020) (60)
Nuclear transit of human zipcode-binding protein IMP1. (2003) (59)
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (58)
ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth (2013) (56)
Hereditary non‐polyposis colorectal cancer (HNPCC): phenotype–genotype correlation between patients with and without identified mutation (2002) (55)
Gene Expression Profiling of Placentas Affected by Pre-Eclampsia (2010) (55)
Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients (2015) (55)
Transcriptional regulation of the human cholecystokinin gene: composite action of upstream stimulatory factor, Sp1, and members of the CREB/ATF-AP-1 family of transcription factors. (1996) (53)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer (2019) (52)
Brain response to traumatic brain injury in wild‐type and interleukin‐6 knockout mice: a microarray analysis (2005) (52)
Copenhagen Prospective Personalized Oncology (CoPPO)—Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials (2018) (51)
Novel de novo BRCA2 mutation in a patient with a family history of breast cancer (2008) (51)
MicroRNA miR-125b induces senescence in human melanoma cells (2011) (51)
De novo mutations in familial adenomatous polyposis (FAP) (2002) (51)
Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype (2011) (50)
Application of whole‐exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the Öresund Region, Scandinavia (2017) (50)
A method for detecting IBD regions simultaneously in multiple individuals--with applications to disease genetics. (2011) (50)
A transgenic mouse marking live replicating cells reveals in vivo transcriptional program of proliferation. (2012) (50)
Microarray‐based classification of diffuse large B‐cell lymphoma (2005) (50)
Distinct repression of translation by wortmannin and rapamycin. (1997) (49)
Gestational Protein Restriction in Mice Has Pronounced Effects on Gene Expression in Newborn Offspring's Liver and Skeletal Muscle; Protective Effect of Taurine (2010) (49)
Novel roles for metallothionein‐I + II (MT‐I + II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: Insights from global gene expression profiling in wild‐type and MT‐I + II knockout mice (2006) (48)
A maternal low protein diet has pronounced effects on mitochondrial gene expression in offspring liver and skeletal muscle; protective effect of taurine (2010) (48)
Nuclear translocation contributes to regulation of DNA excision repair activities. (2009) (47)
Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis. (2000) (47)
Mitogen-activated protein kinase and protein kinase A signaling pathways stimulate cholecystokinin transcription via activation of cyclic adenosine 3',5'-monophosphate response element-binding protein. (1999) (47)
Functional analysis of HNPCC-related missense mutations in MSH2. (2008) (47)
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. (2018) (45)
BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer (2008) (45)
The current epidemic of HPV-associated oropharyngeal cancer: An 18-year Danish population-based study with 2,169 patients. (2020) (45)
Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome? (2000) (45)
Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1. (2004) (42)
Bi-directional routing of DNA mismatch repair protein human exonuclease 1 to replication foci and DNA double strand breaks. (2011) (42)
MicroRNA Changes in Cerebrospinal Fluid After Subarachnoid Hemorrhage (2017) (40)
Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin (2015) (39)
Effect of astrocyte‐targeted production of IL‐6 on traumatic brain injury and its impact on the cortical transcriptome (2008) (39)
Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997–2014: A Nationwide Study (2019) (39)
Expression of the genes dualoxidase2, lipocalin 2 and regenerating islet-derived 1 alpha in Crohn's disease (2007) (38)
Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population (2008) (37)
Influence of Smoking on Colonic Gene Expression Profile in Crohn's Disease (2009) (37)
MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma. (2018) (36)
Prognostic significance of metallothionein in B-cell lymphomas. (2006) (36)
Deregulated Genes in Sporadic Vestibular Schwannomas (2010) (36)
Characterization of miRNA Expression in Human Degenerative Lumbar Disks (2013) (36)
A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members (2009) (35)
Human native lipoprotein-induced de novo DNA methylation is associated with repression of inflammatory genes in THP-1 macrophages (2011) (35)
Drosophila Imp iCLIP identifies an RNA assemblage coordinating F-actin formation (2015) (35)
Nuclear localization of human DNA mismatch repair protein exonuclease 1 (hEXO1) (2007) (35)
The biphasic expression of IMP/Vg1-RBP is conserved between vertebrates and Drosophila (2000) (34)
Integrative analyses reveal novel strategies in HPV11,-16 and -45 early infection (2012) (34)
Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study. (2017) (34)
Molecular Forms and Regional Distribution of Cholecystokinin in the Central Nervous System (1995) (34)
14-3-3 checkpoint regulatory proteins interact specifically with DNA repair protein human exonuclease 1 (hEXO1) via a semi-conserved motif. (2012) (33)
Insulin-like growth factors are mitogens for rat pheochromocytoma PC 12 cells. (1988) (33)
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. (2019) (33)
Molecular signatures of thyroid follicular neoplasia. (2010) (32)
Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994–2014: A Nationwide Study (2017) (31)
Gene expression demonstrates an immunological capacity of the human endolymphatic sac (2015) (31)
Na(v)1.8 channelopathy in mutant mice deficient for myelin protein zero is detrimental to motor axons. (2011) (31)
Functional characterization of MLH1 missense variants identified in lynch syndrome patients (2012) (30)
Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960–2014: a nationwide study (2018) (30)
KCl potentiates forskolin-induced PC12 cell neurite outgrowth via protein kinase A and extracellular signal-regulated kinase signaling pathways (2003) (29)
The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping (2010) (29)
Biosynthesis of 10 kDa and 7.5 kDa insulin-like growth factor II in a human rhabdomyosarcoma cell line (1993) (29)
Human insulin-like growth factor II leader 2 mediates internal initiation of translation. (2002) (28)
Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic (2015) (27)
Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faroe Islands (2005) (27)
A new NFIA:RAF1 fusion activating the MAPK pathway in pilocytic astrocytoma. (2016) (27)
The BTNL2 A allele variant is frequent in Danish patients with sarcoidosis (2011) (27)
Diverging mechanisms for TNF‐α receptors in normal mouse brains and in functional recovery after injury: From gene to behavior (2007) (27)
IGF 2 mRNA-binding protein 2 : biological function and putative role in type 2 diabetes (2009) (26)
Molecular modelling of human red blood cell pyruvate kinase: structural implications of a novel G1091 to a mutation causing severe nonspherocytic hemolytic anemia. (1997) (26)
Differential expression of cellular microRNAs in HPV 11, -16, and -45 transfected cells. (2011) (26)
Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow. (2017) (26)
Expression of histamine receptors in the human endolymphatic sac: the molecular rationale for betahistine use in Menieres disease (2016) (25)
Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer (2016) (25)
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (25)
Receptors for insulin-like growth factors in the central nervous system: structure and function. (1988) (24)
Procholecystokinin as Marker of Human Ewing Sarcomas (2004) (24)
Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment (2018) (24)
Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis (2020) (24)
Gene Expression in the Human Endolymphatic Sac: The Solute Carrier Molecules in Endolymphatic Fluid Homeostasis (2015) (24)
IMP3 Expression in Human Ovarian Cancer is Associated With Improved Survival (2009) (24)
The trans fatty acid elaidate affects the global DNA methylation profile of cultured cells and in vivo (2016) (24)
Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing (2018) (24)
Function of the C−36 to T polymorphism in the human cholecystokinin gene promoter (2000) (24)
The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer (2017) (23)
High Prevalence of Papillary Thyroid Microcarcinoma in Danish Patients: A Prospective Study of 854 Consecutive Patients with a Cold Thyroid Nodule Undergoing Fine-Needle Aspiration (2012) (23)
Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901–2014: a nationwide study (2018) (22)
Genetic screens to identify pathogenic gene variants in the common cancer predisposition Lynch syndrome (2013) (22)
GSK-3&bgr; reduces cAMP-induced cholecystokinin gene expression by inhibiting CREB binding (2004) (22)
Genome‐wide analysis of cytogenetic aberrations in ETV6/RUNX1‐positive childhood acute lymphoblastic leukaemia (2012) (22)
A common Greenlandic Inuit BRCA1 RING domain founder mutation (2009) (22)
Identification of 3 novel VHL germ-line mutations in Danish VHL patients (2012) (22)
Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer. (2001) (22)
Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients (2013) (20)
Personalized oncology: genomic screening in phase 1 (2014) (20)
Polyposis and early cancer in a patient with low penetrant mutations in MSH6 and APC: hereditary colorectal cancer as a polygenic trait (2006) (20)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
RNA assemblages orchestrate complex cellular processes (2016) (20)
Whole genome sequencing of breast cancer (2019) (19)
Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome (2009) (19)
IMP2 axonal localization, RNA interactome, and function in the development of axon trajectories (2016) (19)
Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1 (2010) (19)
Founder Effect of the RETC611Y Mutation in Multiple Endocrine Neoplasia 2A in Denmark: A Nationwide Study. (2017) (19)
Characteristics of the Danish families with multiple endocrine neoplasia type 1 (2006) (18)
Clinical phenotype and gene expression profile in Crohn's disease. (2007) (18)
Deconvolution of autoencoders to learn biological regulatory modules from single cell mRNA sequencing data (2019) (18)
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
High affinity receptors for vasoactive intestinal peptide on a human glioma cell line (1990) (18)
Detection and quantification of microRNA in cerebral microdialysate (2015) (17)
Posttranscriptional regulation of insulin-like growth factor II mRNA. (1995) (17)
Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (2018) (17)
A triple antibody assay for the quantitation of plasma IgG subclass antibodies to acetylcholine receptors in patients with myasthenia gravis. (1985) (17)
Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study (2019) (17)
Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (17)
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations (2010) (16)
A Comparison of Tools for Copy-Number Variation Detection in Germline Whole Exome and Whole Genome Sequencing Data (2021) (16)
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers (2012) (16)
Application of cell-free DNA for genomic tumor profiling: a feasibility study (2019) (16)
Chromothripsis and DNA Repair Disorders (2020) (16)
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers (2019) (15)
A novel DICER1 mutation identified in a female with ovarian Sertoli-Leydig cell tumor and multinodular goiter: a case report (2014) (15)
Genetic screening of the FLCN gene identify six novel variants and a Danish founder mutation (2016) (15)
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
Differential expression of cellular microRNAs in HPV-11 transfected cells. An analysis by three different array platforms and qRT-PCR. (2010) (15)
Gene Loss and Acquisition in Lineages of Pseudomonas aeruginosa Evolving in Cystic Fibrosis Patient Airways (2020) (15)
Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods (2003) (15)
Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients (2016) (15)
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors (2018) (15)
Gene expression, signal transduction pathways and functional networks associated with growth of sporadic vestibular schwannomas (2016) (15)
Single mRNP Analysis Reveals that Small Cytoplasmic mRNP Granules Represent mRNA Singletons. (2019) (15)
Effect of endogenous hypergastrinemia on gastrin receptor expressing human colon carcinoma transplanted to athymic rats. (1995) (15)
The human endolymphatic sac expresses natriuretic peptides (2017) (15)
Composite action of three GC/GT boxes in the proximal promoter region is important for gastrin gene transcription (1999) (14)
Common Genetic Variants and Modification of Penetrance of BRCA 2-Associated Breast Cancer (2010) (14)
Embryonic expression of Drosophila IMP in the developing CNS and PNS. (2009) (14)
Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome (2015) (14)
New tools for quantifying and visualizing adoptively transferred cells in recipient mice. (2003) (14)
Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent Cancer (2018) (13)
Germline RBBP8 variants associated with early-onset breast cancer compromise replication fork stability. (2020) (13)
Regulation of neuronal cholecystokinin gene transcription. (2001) (12)
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome (2020) (12)
Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature (2018) (12)
Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations (2015) (12)
A distal Sp 1‐element is necessary for maximal activity of the human gastrin gene promoter (1995) (12)
Treatment response and colonic gene expression in patients with Crohn's disease (2007) (12)
Development and validation of a microRNA based diagnostic assay for primary tumor site classification of liver core biopsies (2015) (11)
Insulin-like growth factor II: complexity of biosynthesis and receptor binding. (1991) (11)
Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (11)
High-density SNP arrays improve detection of HER2 amplification and polyploidy in breast tumors (2015) (11)
Elevated miR-9 in Cerebrospinal Fluid Is Associated with Poor Functional Outcome After Subarachnoid Hemorrhage (2020) (11)
Molecular subtyping of breast cancer improves identification of both high and low risk patients (2018) (11)
Tumor miRNA expression profile is related to vestibular schwannoma growth rate (2020) (10)
An evaluation of the genetic-matched pair study design using genome-wide SNP data from the European population (2009) (10)
Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma (2020) (10)
Medullary thyroid cancer: RET testing of an archival material (2010) (10)
Unexpectedly high but still asymptomatic iron overload in a patient with pyruvate kinase deficiency. (2004) (10)
Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study (2018) (9)
The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases (2020) (9)
953PA phase 1 study to evaluate the safety and tolerability of bevacizumab-niraparib combination therapy and determine the recommended phase 2 dose (RP2D) in women with platinum-sensitive epithelial ovarian cancer (ENGOT-OV24/AVANOVA1) (2017) (9)
A simple procedure for routine RNA extraction and miRNA array analyses from a single thyroid in vivo fine needle aspirate (2010) (9)
Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997–2013: a nationwide study (2019) (9)
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
Microarrays and Crohn's disease: Collecting reliable information (2005) (9)
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients (2019) (9)
Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols. (2017) (8)
The synthetic NCAM-derived peptide, FGL, modulates the transcriptional response to traumatic brain injury (2008) (8)
HFE mutations and hemochromatosis in Danish patients admitted for HFE genotyping (2002) (8)
Detection of copy number alterations in cell-free tumor DNA from plasma (2017) (8)
Insulin‐like growth factor II mRNA, peptides, and receptors in a thoracopulmonary malignant small round cell tumor (1994) (8)
Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer (2010) (8)
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study (2020) (8)
CARD15 Status and Familial Predisposition for Crohn's Disease and Colonic Gene Expression (2007) (8)
Progression of motor axon dysfunction and ectopic Nav1.8 expression in a mouse model of Charcot-Marie-Tooth disease 1B (2016) (7)
Gene loss and acquisition in lineages of bacteria evolving in a human host environment (2020) (7)
Blau syndrome‐associated mutations in exon 4 of the caspase activating recruitment domain 15 (CARD 15) gene are not found in ethnic Danes with sarcoidosis (2007) (7)
Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer. (2005) (7)
Characterization of the human laminin β2 chain locus (LAMB2): linkage to a gene containing a nonprocessed, transcribed LAMB2-like pseudogene (LAMB2L) and to the gene encoding glutaminyl tRNA synthetase (QARS) (1999) (6)
Using microarray‐based subtyping methods for breast cancer in the era of high‐throughput RNA sequencing (2018) (6)
Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (5)
Modeling tissue contamination to improve molecular identification of the primary tumor site of metastases (2014) (5)
Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status (2021) (5)
Neuronal Fibers and Neurotransmitter Receptor Expression in the Human Endolymphatic Sac. (2017) (4)
Ultra-fast detection and quantification of nucleic acids by amplification-free fluorescence assay. (2020) (4)
Two Types of Receptor for Insulin-Like Growth Factors are Expressed on Normal and Malignant Cells from Mammalian Brain (1987) (4)
A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing (2011) (4)
Genomic Alterations in Human Papillomavirus–Positive and –Negative Conjunctival Squamous Cell Carcinomas (2021) (4)
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study (2020) (4)
Achromobacter spp. genetic adaptation in cystic fibrosis (2021) (4)
Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations (2011) (4)
Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
Copy number variations in affective disorders and meta-analysis (2011) (4)
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer (2022) (4)
Unveiling mRNP composition by fluorescence correlation and cross-correlation spectroscopy using cell lysates (2021) (3)
Cytoplasmic mRNPs revisited: Singletons and condensates (2020) (3)
Biochemical Characterization of MLH 3 Missense Mutations Does Not Reveal an Apparent Role of MLH 3 in Lynch Syndrome (2009) (3)
Regulation of laminin β2 chain gene expression in human cancer cell lines (2001) (3)
The Transcriptional Program of Terminal Granulocytic Differentiation in Man by (2004) (3)
Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy (2019) (3)
Interpretable Autoencoders Trained on Single Cell Sequencing Data Can Transfer Directly to Data from Unseen Tissues (2021) (2)
Regulation of the Human Cholecystokinin Gene (1994) (2)
A simple, safe and sensitive method for SARS‐CoV‐2 inactivation and RNA extraction for RT‐qPCR (2020) (2)
Copenhagen prospective personalized oncology (CoPPO): Sequencing and array-based pipeline for selection of patients to phase 1 studies. (2014) (2)
Universitet IMP 3 RNP safe houses prevent miRNA-directed HMGA 2 mRNA decay in cancer and development (2018) (2)
Isolation of RNP granules. (2011) (2)
Gene expression profiling in patients with polymyalgia rheumatica before and after symptom-abolishing glucocorticoid treatment (2017) (2)
Insulin-like growth factors stimulate growth of cultured fetal rat brain glial cells; possible role of type I receptor kinase activation (1987) (2)
MicroRNA-9-3p: a novel predictor of neurological outcome after cardiac arrest. (2022) (2)
Dynamics of mutant BRAF V600E in free circulating DNA (fcDNA) of non-melanoma cancer patients (pts) in response to treatment with BRAF and MEK/EGFR inhibitors. (2016) (2)
Regulation of laminin beta2 chain gene expression in human cancer cell lines. (2001) (2)
GENE-50. GENOMIC PROFILING AND PRECISION MEDICINE IN GLIOBLASTOMA - A PROSPECTIVE STUDY (2017) (2)
Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation (2016) (2)
Measurement of gut hormone gene expression: mRNA and peptides. (1994) (2)
Achromobacter genetic adaptation in cystic fibrosis (2021) (2)
Amplicon-Based NGS Panels for Actionable Cancer Target Identification in Follicular Cell-Derived Thyroid Neoplasia (2020) (2)
Incidence and characteristics of HPV-associated oropharyngeal cancer: An 18-year Danish population-based study with 2,169 patients (2020) (2)
H19 RNA binds four molecules of IGF-II mRNA-binding protein (2000) (1)
Regulation of cholecystokinin gene expression (2000) (1)
Title Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA 1 and BRCA 2 mutation carriers (2015) (1)
phylogenetic approach identified mitochondrial haplogroup T 1 a 1 as inversely associated with breast cancer risk in BRCA 2 mutation carriers (2015) (1)
Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk (2020) (1)
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients (2019) (1)
The Predictive Value of Gene Expression Profiles for Acute Graft-Versus-Host Disease after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Hematological Malignancy. (2007) (1)
Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations (2014) (1)
Correlation between HPV status at T and N sites of oropharyngeal squamous cell carcinomas (2017) (1)
Single mRNP analysis by super-resolution microscopy and fluorescence correlation spectroscopy reveals that small mRNP granules represent mRNA singletons (2019) (1)
Molecular profiling of tumour budding to implicate TGF-β mediated epithelial-mesenchymal transition as a therapeutic target. (2015) (1)
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (1)
Characterization of basal-like subtype in a Danish consecutive primary breast cancer cohort (2018) (1)
Genetic adaptation and transmission of Achromobacter in cystic fibrosis (2020) (1)
Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype (2012) (1)
A catalog of curated breast cancer genes (2021) (1)
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status (2021) (0)
Gastrin and gastrin receptor gene expression in pancreatic cancer: Evidence for autocrine growth stimulation (1996) (0)
S12.43 Gene expression profiling of liver and skeletal muscle in newborn mice exposed to an in utero low protein diet with or without taurine (2008) (0)
Expression but Incomplete Colorectal Carcinomas Maturation of Progastrin in (1993) (0)
Subject Index Vol. 84, 1999 (1999) (0)
Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin (2015) (0)
University of Southern Denmark Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997- 2014 (2019) (0)
New pathogenic germline variants identified in mesothelioma. (2023) (0)
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact (2022) (0)
High-density SNP arrays improve detection of HER2 amplification and polyploidy in breast tumors (2015) (0)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
Abstract 3140: Differential clonal selection in tumor tissue and cell-free DNA from a neratinib-treated refractory breast cancer patient harboring an activating ERBB2 (HER2) mutation (2016) (0)
Elevated miR-9 in Cerebrospinal Fluid Is Associated with Poor Functional Outcome After Subarachnoid Hemorrhage (2020) (0)
[How far are we from the clinical use of array technology?]. (2005) (0)
Predisposing factors in iron overloaded patients with liver disease in relation to HLA-H genotype (1998) (0)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
Gene Expression in Relation to Vestibular Schwannoma Growth Pattern (2012) (0)
Copenhagen prospective personalized oncology (CoPPO): Genomic profiling to select patients for phase 1 trials (2016) (0)
Benchmarking full-length transcript single cell mRNA sequencing protocols (2020) (0)
Abstract 444: Dynamics of tumor mutations in paired samples from glioblastoma patients during treatment (2021) (0)
Targeted genome sequencing of negative and positive human papillomavirus induced conjunctival carcinomas (2019) (0)
Brussel Plasticity of adult human pancreatic duct cells by neurogenin 3-mediated reprogramming (2012) (0)
Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy (2019) (0)
Vestibular Schwannoma Gene Expression Analysis in Relation to Tumor Growth Pattern: Preliminary Findings (2005) (0)
Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A. (1985) (0)
University of Southern Denmark Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997-2014 A Nationwide (2019) (0)
Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype (2012) (0)
Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature (2018) (0)
Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients (2016) (0)
Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype (2012) (0)
Degeneration and Regeneration of Peripheral Motor Axons Is Impaired in Mice Heterozygously Deficient for the Myelin Protein P0 Gene (IN1-2.001) (2012) (0)
Detection and quantification of microRNA in cerebral microdialysate (2015) (0)
Intestinal metaplasia is a precursor lesion for sinonasal intestinal‐type adenocarcinoma: genomic investigation of a case proving this hypothesis (2021) (0)
with next-generation sequencing Quantitative miRNA expression analysis : Comparing microarrays Material Supplemental (2009) (0)
Deconvolution of autoencoders to learn biological regulatory modules from single cell mRNA sequencing data (2019) (0)
q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers (2012) (0)
Classification d'arnm de néoplasie folliculaire thyroïdienne (2010) (0)
The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study (2022) (0)
GENE-30. INCREASED TUMOR MUTATIONAL LOAD AFTER RADIOTHERAPY AND TEMOZOLOMIDE IN PROGRESSING GLIOBLASTOMA A PROSPECTIVE STUDY (2018) (0)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
Subcellular localization of human exonuclease 1 (2005) (0)
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors Ahlborn, (2018) (0)
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2. (2023) (0)
The trans fatty acid elaidate affects the global DNA methylation profile of cultured cells and in vivo (2016) (0)
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer (2019) (0)
1072 Mir-449 Inhibits Growth of Gastric Cancer Cells Partly By Inhibiting the Expression of Met and Amphiregulin (2009) (0)
Actionable targets in recurrent bile duct and pancreatic cancer in a prospective cohort of patients evaluated by whole exome sequencing and SNP array analysis. (2016) (0)
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (0)
[Microarray data analysis]. (2006) (0)
Shared heritability and functional enrichment across six solid cancers (2019) (0)
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy (2023) (0)
Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
Different Subtypes of Difffuse Large B-Cell Lymphomas Identified Using Microarrays and Phenotyping. (2004) (0)
SY2-1: Insulin-like growth factor 2 mRNA binding proteins (IMP/IGF2BP) as mRNA safe houses in cancer and development (2014) (0)
Correction to: Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma (2020) (0)
Characterization of miRNA Expression in Human Lumbar Disks (2012) (0)
Differences in gene expression despite identical histomorphology in sinonasal intestinal‐type adenocarcinoma and metastases from colorectal adenocarcinoma (2022) (0)
Fluorescence Correlation and Cross-Correlation Spectroscopy Unveil Cytoplasmic mRNP Composition and Dynamics (2020) (0)
337: The Predictive Value of Gene Expression Profiles for Acute Graft-Versus-Host Disease after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Hematological Malignancy (2008) (0)
[Diagnosis of neuroendocrine tumours in the gastrointestinal tract]. (2010) (0)
Genomewide analysis of cytogenetic aberrations in ETV 6 / RUNX 1 positive childhood acute lymphoblastic leukaemia (2017) (0)
Differenced between gene expression after 90% and 70% hepatectomy (2003) (0)
O33. MicroRNA alterations in oral and pharyngeal squamous cell carcinoma (2009) (0)
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (0)
Survival and characteristics of 772 patients with oropharyngeal cancer and specific human papillomavirus genotypes: A Danish population-based study from 2011-2017 (2020) (0)
Drosophila Imp iCLIP identifies an RNA assemblage coordinating F-actin formation (2015) (0)
Abstract 149: Elevated mir-9 in Cerebrospinal Fluid is Associated With Poor Functional Outcome After Subarachnoid Hemorrhage (2019) (0)
Supplementation of estrogen and progesterone to postmenopausal women (1996) (0)
Prognostic Impact of Subclonal TP53 Aberrations in Chronic Lymphocytic Leukemia Validated By a Robust Targeted Next Generation Sequencing Assay (2016) (0)
Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype (2012) (0)

This paper list is powered by the following services:

Other Resources About Finn Cilius Nielsen

forskning.ku.dk

What Schools Are Affiliated With Finn Cilius Nielsen?

Finn Cilius Nielsen is affiliated with the following schools:

University of Copenhagen
University of Cambridge

Finn Cilius Nielsen's Academic­Influence.com Rankings